Did anyone find out anything as to when our Phase III review with the FDA is supposed to be. I thought it was suppose to be late October but we are almost past that now. In the conference call from last week, it was obvious that a lot of info had been put out prior to it starting and I was wondering therefore if this matter was discussed. I wish Rigl put out more PRs for investors.